Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 17,961–17,980 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.

by Lloyd Inc

Reason
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Recall initiated
February 24, 2012
Reported by FDA
July 4, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601

by Lloyd Inc

Reason
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Recall initiated
February 24, 2012
Reported by FDA
July 4, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01. Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc

Reason
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Recall initiated
February 3, 2012
Reported by FDA
July 4, 2012
Distribution
Nationwide and PR.

View recall →

Drug Recall Terminated Historical recordClass II

Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc

Reason
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Recall initiated
February 3, 2012
Reported by FDA
July 4, 2012
Distribution
Nationwide and PR.

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Tablets, USP, 4 mg, 20 tablets per bottle, Repacked & Distributed by: Physicians Total Care Inc., Tulsa, OK 74146, NDC # 54868-2913-03

by Physicians Total Care, Inc.

Reason
Impurities/Degradation Products; Product is being recalled due to the potential of not meeting the Impurity C specification through the product shelf life
Recall initiated
March 18, 2011
Reported by FDA
July 4, 2012
Distribution
GA, PA

View recall →

Drug Recall Terminated Historical recordClass III

Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.

by Hospira, Inc.

Reason
Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
Recall initiated
April 5, 2012
Reported by FDA
June 27, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Lipitor (Atorvastatin calcium); 40 mg, 30 TABLETS, Rx only, Repacked & distributed: Physicians Total Care, Inc., Tulsa OK 74146, NDC 54868-4229-0

by Physicians Total Care, Inc.

Reason
Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.
Recall initiated
February 8, 2012
Reported by FDA
June 27, 2012
Distribution
AK, NC, GA

View recall →

Drug Recall Terminated Historical recordClass II

Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05

by Abbott Laboratories

Reason
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
Recall initiated
May 14, 2012
Reported by FDA
June 27, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Hands Down Medicated Lotion Soap, 1 gallon bottle, 4 gallons per case, Distributed by PCS Industries, Crestwood, IL, 60446

by Kutol Products Co Inc

Reason
Labeling: Presence of Undeclared Additive: Medicated lotion soap produced and distributed by the recalling firm contains the unapproved ingredient, Red Dye #15. This dye is not approved for use in food, drugs or cosmetics.
Recall initiated
May 21, 2012
Reported by FDA
June 27, 2012
Distribution
IL

View recall →

Drug Recall Terminated Historical recordClass I

Morphine Sulfate Immediate Release tablet, 30 mg/120 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, OK 74146-6234, NDC 54868-4973-00

by Physicians Total Care, Inc

Reason
Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.
Recall initiated
November 10, 2010
Reported by FDA
June 27, 2012
Distribution
FL

View recall →

Drug Recall Terminated Historical recordClass I

Morphine Sulfate Extended Release tablet, 30 mg, 60 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, Ok 74146-6234, NDC 54868-4033-00

by Physicians Total Care, Inc

Reason
Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.
Recall initiated
November 10, 2010
Reported by FDA
June 27, 2012
Distribution
FL

View recall →

Drug Recall Terminated Historical recordClass III

Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

by Teva Pharmaceuticals USA, Inc.

Reason
Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.
Recall initiated
April 23, 2012
Reported by FDA
June 27, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

LifeGas OXYGEN COMPRESSED UN1072 USP, Distributed by: Linde

by Linde Gas LLC

Reason
CGMP Deviations: The pressure gages, vacuum gages, and thermometer had surpassed the calibration expiry period, which may have resulted in overfill/underfill of oxygen cylinders.
Recall initiated
May 4, 2012
Reported by FDA
June 27, 2012
Distribution
Distributed only within Ohio. No Federal Government, foreign or Canadian consignees received product.

View recall →

Drug Recall Terminated Historical recordClass II

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

by Hospira, Inc.

Reason
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
Recall initiated
April 11, 2012
Reported by FDA
June 20, 2012
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE 68501; NDC 60951-797-70.

by Endo Pharmaceuticals, Inc.

Reason
Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.
Recall initiated
May 7, 2012
Reported by FDA
June 20, 2012
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070

by Quadrant Chemical Corporation

Reason
Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.
Recall initiated
March 20, 2012
Reported by FDA
June 20, 2012
Distribution
Maine

View recall →

Drug Recall Terminated Historical recordClass II

Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tablets per bottle (NDC 54868-4165-1); b) 60-count tablets per bottle (NDC 54868-4165-0); Rx only, Mfg. By: G.D. searle LLC Div Pfizer, New York, NY 10017; Repacked & distributed by: Physicians total Care, Inc., Tulsa, OK 74146.

by Physicians Total Care, Inc.

Reason
Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.
Recall initiated
September 19, 2011
Reported by FDA
June 20, 2012
Distribution
NC and KY

View recall →

Drug Recall Terminated Historical recordClass II

CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.

by Luitpold Pharmaceuticals, Inc.

Reason
Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.
Recall initiated
March 15, 2011
Reported by FDA
June 20, 2012
Distribution
Nationwide, Puerto Rico, and Abu Dhabi

View recall →

Drug Recall Terminated Historical recordClass II

Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.

by Ben Venue Laboratories Inc

Reason
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Recall initiated
May 1, 2012
Reported by FDA
June 20, 2012
Distribution
Nationwide and Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Midazolam HCl Injection, 5 mg/mL, 1 mL single use vials, packaged in 10 x 1 mL single use vials per pack, Rx only, Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; Manufactured for: Bedford Laboratories, Bedford, OH 44146, NDC 55390-138-01; UPC 3 55390-138-01 8.

by Ben Venue Laboratories Inc

Reason
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Recall initiated
May 1, 2012
Reported by FDA
June 20, 2012
Distribution
Nationwide and Puerto Rico.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.